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Classical DNA sequencing (sometimes referred to as first 
generation sequencing) was developed in the late 1970s 
and  evolved  from  a  low-throughput,  almost  ‘artisan’ 
approach, in which the same radiolabeled DNA sample 
was run on a gel with one lane for each nucleotide [1,2], 
to an automated method in which all four fluorescently 
labeled  dye  terminators  for  a  single  sample  [3]  were 
loaded onto individual capillaries. These capillary-based 
instruments, introduced in 1998, could handle hundreds 
of individual samples per week, in a manner sufficiently 
powerful that the first draft sequence of a human genome 
was  finished  in  2001  using  this  technology.  In  the 
intervening years, incremental improvements have been 
made in dye chemistry, DNA polymerases, and electro-
phoresis conditions, pushing read lengths up to 1,000 bp; 
however,  the  underlying  technology  has  remained  the 
same, sequencing individual clones or samples.
After more than 25 years of steady improvements in 
first generation sequencing technology, the next genera-
tion  of  sequencing  technology  (now  called  second 
genera  tion; see Box 1 for discussion of third generation 
sequencing  terminology)  emerged  in  2005  with  an 
immediate  100-fold  increase  in  sequencing  throughput 
using the 454 pyrosequencing approach [4]. This advance 
was  followed  by  introductions  of  other  technologies 
(such as Solexa/Illumina and ABI SOLiD) that varied in 
their  technological  details  but  increased  sequencing 
throughput  and  reduced  costs  by  additional  orders  of 
magnitude (reviewed in [5-7]). These second generation 
technologies  drastically  increased  throughput  because 
the sequencing target had changed from single clones or 
samples to many independent DNA fragments, enabling 
large  sets  of  DNAs  to  be  sequenced  in  parallel.  Until 
recently,  all  second  generation  technologies  achieved 
massively parallel sequencing by imaging light emission 
from the sequenced DNA, although the new sequencing 
system  from  Ion  Torrent  will  probably  be  the  first 
commercial system to change that paradigm by detecting 
hydrogen  ions  instead  of  light  [8].  However,  the  key 
advance in all second generation technologies has been 
the avoidance of the bottleneck that resulted from the 
individual  preparation  of  DNA  templates  that  first 
genera  tion  approaches  required.  When  coupled  with 
powerful  new  bioinformatic  tools  and  computational 
capabilities  optimized  for  these  new  technologies,  a 
prodigious increase in data output has resulted. This is 
high  lighted  in  Figure  1,  where  the  accumulation  of 
sequence in classical GenBank from its inception in 1982 
is  compared  with  data  in  the  Sequence  Read  Archive 
(originally  known  as  the  Short  Read  Archive,  both 
abbreviated SRA). Less than a year after its initiation, the 
SRA had already surpassed classical GenBank and it now 
accounts  for  over  95%  of  all  new  sequence  deposits. 
Furthermore, this is likely to be an under-representation 
of  the  level  of  new  sequencing  results  because  of  the 
challenges  of  incorporating  the  new  data  types  and 
difficulties in transferring the large volume of data.
Although  the  second  generation  technologies  were 
initially inferior to classical sequencing in terms of read 
length  (about  35  nucleotides  (nt)  for  Illumina  versus 
about  700  nt  for  classical  sequencing)  and  single-read 
error rate (about 2% versus less than 0.1%), these short-
comings could be overcome by the sheer volume of data. 
Furthermore,  continuous  improvements  in  sequencing 
chemistry have narrowed the gap with respect to read 
length  and  errors,  as  exemplified  by  Roche  454  now 
routinely  achieving  read  lengths  of  400  nt  at  >99% 
accuracy  [9]  and  Illumina  moving  from  an  initial  read 
length of 36 nt to the current 76 nt or more and raw error 
rates  well  below  1%.  These  technologies  have  allowed 
DNA  sequencing  to  move  beyond  a  method  for 
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Here we review the properties and applications of this 
rapidly evolving and promising technology.
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which sequencing has become the digital measuring stick 
for  a  host  of  important  biological  processes,  including 
gene expression, splicing, characterizing complex mixed 
populations of organisms, detecting protein binding, and 
defining genome methylation sites [10].
Single-molecule sequencing provides solutions to some 
of the most vexing problems that face second generation 
sequencing by simplifying sample preparation, reducing 
sample mass requirements, and eliminating amplification 
of DNA templates. Every sample manipulation and espe-
cially amplification can cause quantitative and qualitative 
artifacts [11]; these have especially detrimental impacts 
on quantitative applications, such as chromatin immuno-
precipitation  sequencing  (ChIP-Seq)  and  RNA/cDNA 
sequencing. Amplification also places limitations on the 
size of the DNA being sequenced because molecules that 
are too short or too long will not be amplified well. The 
simplified  sample  preparation  and  higher  consistency 
caused  by  eliminating  amplification  makes  single-
molecule  sequencing  well  suited  for  diagnostic  and 
clinical applications [12]. Thus, the need for continuing 
advances in sequencing technology is apparent.
Because  the  properties  of  different  single-molecule 
sequencing technologies vary so much from each other 
and from other generations of sequencing technologies, 
it is important to understand those properties and their 
impact on experimental design and output. Some advan-
tages  of  single-molecule  sequencing  may  be  universal, 
such  as  the  ability  to  resequence  the  same  molecule 
multiple times for improved accuracy and the ability to 
sequence  molecules  that  cannot  be  readily  amplified 
because of extremes of GC content, secondary structure, 
or  other  reasons.  The  ability  to  make  use  of  some  of 
these  advantages,  such  as  long  read  length  and 
quantitative  superiority,  depends  on  the  details  of  the 
technology, as not all single-molecule technologies have 
the same per  for  mance characteristics - in terms of long 
read length or the throughput in terms of read count - to 
be appropriate for all applications. Other reviews have 
examined  various  aspects  of  different  single-molecule 
technologies [5-7,13-17]. Here, we focus on the unique 
attributes of each technology (Figure 2) and how each 
might  be  best  used  to  answer  questions  of  biological 
interest that are not well addressed by current first and 
second generation sequencing.
Single-molecule sequencing technologies
When  considering  the  properties  of  single-molecule 
sequencing technologies, the focus is most frequently on 
read length, error rate, and throughput (Figure 3); how-
ever,  input  sample  quantity  and  quality  requirements, 
simplicity and parallelizability of sample preparation, and 
data analysis are also important components that must 
be factored in when considering whether a technology, 
single-molecule or otherwise, is appropriate for a given 
problem. Some of the applications frequently undertaken 
with  current  sequencing  technologies  and  the  relative 
importance of various properties of different sequencing 
methods are shown in Table 1. Important properties of 
single-molecule technologies that relate to these various 
applications are discussed below.
Sequencing by synthesis
The first commercially available single-molecule sequen-
cing system was developed by our colleagues at Helicos 
BioSciences [18]. In this system, individual molecules are 
hybridized  to  a  flow  cell  surface  containing  covalently 
attached oligonucleotides. Fluorescently labeled nucleo-
tides and a DNA polymerase are added sequentially and 
incorporation  events  detected  by  laser  excitation  and 
recording with a charge coupled device (CCD) camera. 
The fluorescent ‘Virtual Terminator’ nucleotide prevents 
the incorporation of any subsequent nucleotide until the 
nucleotide dye moiety is cleaved [19]. The images from 
each  cycle  are  assembled  to  generate  an  overall  set  of 
sequence reads. On a standard run, 120 cycles of nucleo-
tide addition and detection are carried out. Well over a 
billion molecules can be followed simultaneously in this 
Box 1
The logical term for the next round of sequencing technology 
advances would be ‘third generation sequencing’ and this has 
frequently been used to describe single-molecule sequencing. 
However, third generation sequencing has also been defined 
by some as real-time sequencing or solid-state sequencing, so 
the term has achieved Alice in Wonderland status of meaning 
whatever its user wants it to mean, and it will therefore not be 
used here. Instead, the more precise term of single-molecule 
sequencing will be used and only for those technologies that 
actually generate a sequencing signal from a single nucleic 
acid molecule. The definition of single-molecule sequencing 
has been stretched by some to include systems that start with 
a single molecule but then make multiple copies of the DNA 
before sequencing or detection [67]. However, the properties 
of any sequencing system could be stretched to assert that the 
sequencing process actually started with a single molecule, even 
though the unique advantages of single-molecule sequencing 
would be lost. On the other hand, there are also technologies 
that do not strive to generate sequence information from every 
nucleotide but only from a subset of positions. When such partial 
sequences are generated from a single molecule, this single-
molecule mapping data can be combined with sequence data 
for a complete genomic view. Indeed, no current technology 
can provide individual read lengths sufficient for whole genome 
coverage of even the smallest organisms, so methods for 
combining partial reads into a complete coverage map are an 
important component of the overall sequencing process for 
whole genomes.
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Page 2 of 10approach. Because there are two 25-channel flow cells in 
a standard run, 50 different samples can be sequenced 
simultaneously, with the additional possibility of signifi-
cantly greater throughput of samples through multiplex-
ing. Sample requirements are the simplest of all techno-
logies:  sub-nanogram  amounts  are  necessary  and  very 
poor quality DNA, including degraded or modified DNA, 
can  be  sequenced  [20,21].  Average  read  lengths  are 
relatively short (about 35 nt) with raw individual nucleo-
tide  error  rates  currently  about  3  to  5%,  occurring 
randomly throughout the sequence reads and predomi-
nantly in the form of a ‘dark base’ or deletion error, which 
is  accounted  for  in  the  alignment  algorithm  [22].  This 
error rate is not an issue when detecting polymorphisms 
because  30x  coverage  is  typically  used  for  diploid 
genomes  with  second  generation  systems  to  overcome 
the  uneven  coverage  induced  by  amplification.  Over-
sampling is needed to overcome the stochastic nature of 
heterozygote  detection,  with  30x  coverage  advisable  to 
ensure that nearly all heterozygotes are called correctly. 
At this coverage level, accurate consensus sequences are 
generated  regardless  of  error  rates  within  this  range. 
Single-molecule  systems  have  a  much  more  even 
coverage  and  thus  do  not  require  as  much  depth  for 
complete detection of heterozygotes. The even coverage 
relative  to  second  generation  systems  was  shown  with 
ChIP experiments, in which sequence reads were rela-
tively constant with respect to GC content with single-
molecule  sequencing,  whereas  significant  deviations 
were  observed  at  both  high  and  low  GC  content  with 
amplification-based  sequencing  [23]  and  with  whole-
genome sequencing of a human sample [24].
The Helicos Sequencer system can also sequence RNA 
molecules  directly,  thus  avoiding  the  many  artifacts 
associated with reverse transcriptase and providing un-
paralleled  quantitative  accuracy  for  RNA  expression 
measurements [25]. The very high read count per sample 
allows precise expression measurements to be made with 
either RNA or cDNA [26-29], a feature not yet possible 
with other single-molecule technologies. Indeed, whole 
classes of RNA molecules that cannot be visualized using 
other technologies can be detected using a single-mole-
cule  approach  [30,31].  As  with  many  single-molecule 
systems,  repeated  reads  of  the  same  molecule  can 
Figure 1. Sequence database submissions from 1982 to 2010. Nucleotides submitted to the classical version of GenBank (diamonds, thin line) 
and to the Sequence Read Archive (circles, thick line) are shown as a function of time. Data for GenBank up to 2008 were obtained from the NCBI 
website [68] and subsequent years were obtained from GenBank publications [69,70]. Data for SRA was obtained from publications for 2008 to 
2010 [71-73] and estimated for 2007 on the basis of 44 projects being in the database at the end of the year [74] and using February 2008 data from 
NCBI [75] to estimate the approximate number of bases likely to have been submitted from that spectrum of projects. Key advances in sequencing 
technology are shown with arrows. The development of second generation sequencing technologies and single-molecule sequencing has had 
a dramatic increase in the number of sequences deposited in public databases. Less than a year after its initiation, the SRA had already surpassed 
classical GenBank and it now accounts for over 95% of all new sequence deposits.
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Page 3 of 10Figure 2. Overview of single-molecule sequencers. The three most advanced single-molecule sequencing systems all carry out sequencing-by-
synthesis using laser excitation to generate a fluorescent signal from labeled nucleotides, which is then detected using a camera. (a) In the Helicos 
BioSciences system [18], single nucleotides, each with a fluorescent dye attached to the base, are sequentially added. (b,c) In the Pacific Biosciences 
[35] and Life Technologies [41] systems, four different nucleotides, each with a different color dye attached to the phosphates, are continuously 
added. Background fluorescence is minimized differently in the three systems. (a) Helicos uses total internal reflectance fluorescence (TIRF) to create 
a narrow evanescent field of light in which the intensity of the light decays exponentially away from the glass surface. Only dyes that are in the 
TIRF evanescent field can fluoresce. (b) Pacific Biosciences uses a zero mode waveguide (ZMW), which limits illumination to a narrow region near 
the bottom of the well containing the polymerase. Only dyes near the opening of the ZMW can fluoresce. (c) Life Technologies uses fluorescence 
resonance energy transfer (FRET) between the initially absorbing quantum dot on the polymerase and the emitting dye on the nucleotide. Only 
dyes close to the polymerase-attached quantum dot can be excited by FRET and then fluoresce. For the three systems, DNA is immobilized for 
viewing over time by a surface-attached sequencing primer (Helicos (a)), by interaction with a surface-bound polymerase (Pacific Biosciences (b)), 
or by ligating to a surface-attached oligonucleotide (Life Technologies (c)). For Helicos (a), the polymerase is replaced after every cycle of nucleotide 
addition. For Life Technologies (c), the polymerase can be replaced on a given DNA molecule after each read is completed. For Pacific Biosciences 
(b), the polymerase cannot be replaced.
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Page 4 of 10markedly improve the error rate and also allow detection 
of very rare variants in a mixed sample. For example, a 
rare  variant  in  a  sample  containing  a  mixture  of  few 
tumor  cells  among  many  normal  cells  might  not  be 
detectable with amplified DNA. With repeat sequencing 
of  the  same  molecule,  the  error  rate  can  be  driven 
sufficiently low that mutations in heterogeneous samples 
such as tumors can be readily detected. Because of the 
minimal  sample  preparation  needs,  the  ability  to  use 
exceptionally small starting quantities, and the high read 
count, this technology is ideal for quantitative applica-
tions such as ChIP, RNA expression, and copy number 
variation,  and  situations  in  which  sample  quantity  is 
limiting  or  degraded  [20,23].  Standard,  whole  human 
genome resequencing is readily accomplished [24], but it 
is currently less expensive on second generation systems.
Pacific Biosciences has developed another sequencing-
by-synthesis  approach  using  fluorescently  labeled 
nucleotides. In this system, DNA is constrained to a very 
small volume in a zero-mode wave guide [32] and the 
presence  of  a  fluorescently  labeled  cognate  nucleotide 
near the DNA polymerase is measured. The dimensions 
of the wave guide are so small that light can penetrate 
only the region very close to the edge, where the poly-
merase used for sequencing is constrained. Only nucleo-
tides in that small volume near the polymerase can be 
illuminated  and  fluoresce  for  detection.  Because  the 
nucleotide  that  is  being  incorporated  in  the  extending 
DNA strand spends a longer time near the polymerase, it 
can, to a large extent, be distinguished from non-cognate 
nucleotides. All four potential nucleotides are included in 
the reaction, each labeled with a different color fluores-
cent  dye  so  that  they  can  be  distinguished  from  each 
other. Each nucleotide has a characteristic incorporation 
time  that  can  further  aid  in  improving  base  calls. 
Sequence reads of up to thousands of bases, longer than 
possible with second generation systems, are obtained in 
real time for each individual molecule [33-36]. However, 
the current throughput is less than 100,000 reads per run, 
so the overall sequence yield is much lower than second 
generation systems and the Helicos system. In addition, 
the raw error rate, currently 15 to 20% [37,38], is signifi-
cantly  higher  than  with  any  other  current  sequencing 
technology, creating challenges in using the data for some 
applications, such as variant detection.
Much longer reads, referred to as ‘strobe reads’ [39], 
can be generated by turning off the laser for periods of 
time  during  sequencing,  which  prevents  premature 
termi  nation caused by laser-induced photodamage to the 
polymerase  and  nucleotides.  If  long  reads  are  not 
necessary, the high raw error rate can be overcome by 
ligating  a  hairpin  oligonucleotide  to  each  end  of  the 
DNA, creating a circular template (called SMRTbell for 
single molecule real time), and then repeatedly sequen-
cing the same molecule [37]. This procedure works when 
the molecules are relatively short but it cannot be used 
with long reads, so those retain the high raw error rate. 
Even with a high error rate, the very long reads can be 
productively  used  for  joining  sequence  contigs.  An 
additional benefit for this system is the ability to poten-
tially  detect  modified  bases.  It  is  possible  to  detect 
5-methylcytosine  [40],  although  the  role  of  sequence 
context  and  other  factors  in  affecting  the  accuracy  of 
such  assignments  remains  to  be  clarified.  In  principle, 
direct RNA sequencing should also be possible with this 
system,  but  this  has  not  been  reported  yet  for  natural 
RNA molecules because nucleotides bind repeatedly to 
the reverse transcriptase before nucleotide incorporation, 
thereby giving false signals with multiple insertions that 
prevent  determination  of  a  meaningful  sequence.  In 
addition, the low read count of this system will limit it to 
the  identification  of  common  mRNA  isoforms  rather 
than quantitative expression profiling or complete trans-
criptome coverage, both of which require a much higher 
read  count  than  possible  in  the  foreseeable  future.  In 
general, the long reads and short turnaround time make 
this system most useful for helping to assemble genomes, 
assessing the analysis of structural variation, haplotyping, 
metagenomics, and identification of splicing isoforms.
Life Technologies, a major provider of both first and 
second generation sequencing systems, is developing the 
fluorescence  resonance  energy  transfer  (FRET)-based 
single-molecule  sequencing-by-synthesis  technology 
initially introduced by Visigen [41]. Substantial advances 
have  been  made,  with  commercial  release  of  the 
Figure 3. The attributes of single-molecule sequencing 
technology. The current read counts and read lengths for single-
molecule sequencing technologies are shown by the dots. Each 
technology is striving for improvements in their key attributes with 
the research aimed in the directions shown by the arrow.
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tech  nology consists of a quantum-dot-labeled polymer-
ase  that  synthesizes  DNA  using  four  distinctly  labeled 
nucleotides  in  a  real-time  system  [42].  Quantum  dots, 
which are fluorescent semiconducting nanoparticles, have 
an advantage over fluorescent dyes in that they are much 
brighter and less susceptible to bleaching, although they 
are also much larger and more susceptible to blinking. 
The  genomic  sample  to  be  sequenced  is  ligated  to  a 
surface-attached oligonucleotide of defined sequence and 
then read by extension of a primer complementary to the 
surface  oligonucleotide.  When  a  fluorescently  labeled 
nucleotide binds to the polymerase, it interacts with the 
quantum dot, causing an alteration in the fluorescence of 
both the nucleotide and the quantum dot. The quantum 
dot signal drops, whereas a signal from the dye-labeled 
phosphate  on  each  nucleotide  rises  at  a  characteristic 
wavelength. The real-time sequence is captured for each 
extending primer. Because each sequence is bound to the 
surface,  it  can  be  reprimed  and  sequenced  again  for 
improved  accuracy.  It  is  not  clear  what  the  sequence 
specifications  will  be  but  its  similarity  to  the  Pacific 
Biosciences technology make that a likely reference point. 
If so, it will have the same strengths in terms of applica-
tions (genome assembly, structural variation, haplo  typ-
ing, metagenomics) whereas potentially being challenged 
with quantitative applications requiring a high read count 
(such as ChIP or RNA expression).
Optical sequencing and mapping
There are other technologies that enable very long reads 
to  be  produced  but  at  the  cost  of  significantly  lower 
throughput.  For  example,  it  is  possible  to  adhere  very 
long DNA molecules, up to hundreds of kilobases long, 
to surfaces and interrogate them for particular sequences 
by  cutting  them  with  various  restriction  enzymes  or 
labeling  them  after  treatment  with  sequence-specific 
nicking enzymes. The lengths of the examined molecules 
are dependent on the ability to handle such long DNA 
without  mechanically  shearing  it.  Complete  restriction 
digests that allow ordering of sequence contigs have been 
generated for human and other genomes from collections 
of single molecules spanning entire genomes [43]. Highly 
repetitive  and  duplicated  genomes,  such  as  maize,  are 
particularly difficult to assemble with traditional sequen-
cing but have been successfully analyzed with this single-
molecule  system  [44].  The  restriction  sites  provide 
sequence landmarks on the DNA and thus long repeat 
regions and other intricate structural variations can be 
assigned in an unambiguous manner. Specialized applica-
tions  such  as  genome-wide  methylation  mapping  can 
also be undertaken [45].
Similarly,  DNA  molecules  can  be  constrained  to 
nanotubes and specifically labeled for viewing [46]. Single 
molecules of RNA have been visualized using scanning 
tip Raman spectroscopy [47]. In an alternative method 
also  using  adsorption  of  long  DNA  molecules  to  a 
surface, guanines could be distinguished from all other 
bases  and  the  partial  sequence  read  with  a  scanning 
electron microscope [48]. Possibilities for reading other 
bases through insertion of heavy atoms such as bromine 
or iodine on particular nucleotides have been suggested 
by ZS Genetics [49]. Although the low strand throughput 
and incomplete sequence reading are currently limiting, 
there is potential for reads that are hundreds of kilobases 
long, again limited primarily by the ability to handle the 
DNA  without  shearing  it.  Other  technologies  using 
direct  reading  of  stretched  DNA  have  been  reviewed 
else  where  [7].  These  optical  sequencing  technologies 
pro  vide a powerful view of genome structure, but they 
cannot provide the detailed sequence data or access to 
many  other  sequencing  applications  that  require  high 
read counts, such as gene expression measurements.
Nanopores
All of the sequencing techniques described so far require 
some kind of label on the DNA or nucleotide substrates 
to detect the individual base for sequencing. However, 
nanopore  approaches  generally  do  not  require  an 
exogenous  label  but  rely  instead  on  the  electronic  or 
chemical structure of the different nucleotides for discri-
mi  nation. The advantages and potential means of using 
nanopores  have  been  reviewed  [14,50].  Nanopores  of 
greatest interest thus far include those assembled with 
solid-state  systems  constructed  of  materials  such  as 
carbon  nanotubes  or  thin  films  [51-54]  and  the  bio-
logically  based  α-hemolysin  [55-59]  or  MspA  [60,61]. 
These  bacterial  pore  proteins  have  been  extensively 
studied  and  engineered  to  optimize  the  detection  of 
specific bases and the translocation rate of DNA through 
the pore. Although sequencing native DNA based on its 
natural properties would eliminate the labeling step and 
potentially  allow  very  long  reads  with  minimal  sample 
preparation, thus reducing costs, the differences among 
nucleotides  are  very  modest  and  their  detection  is 
compounded by difficulties in controlling the pace and 
directionality of the DNA through the nanopore. Specific 
detection and unidirectional flow are required for high 
accuracy sequencing.
A variety of methods have been used to slow the pace 
of  DNA  through  nanopores,  including  attachment  of 
poly  styrene beads [53], salt concentrations [62], viscosity 
[63],  magnetic  fields  [64],  and  the  introduction  of 
regions  of  double-stranded  DNA  on  a  single-stranded 
target [54,58]. At the high translocation speeds typically 
found  (potentially  millions  of  bases  per  second), 
detecting  a  signal  over  background  noise  from  each 
nucleotide  can  be  a  challenge,  and  this  has  been 
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(such as by using hybridization of known sequences as is 
being  developed  by  NabSys  [53])  or  encoding  the 
original  sequence  in  a  more  complex  manner  by 
converting the nucleotide sequence using a binary code 
of  molecular  beacons  (as  is  being  developed  by 
NobleGen  [65]).  Maintaining  a  unidirectional  flow  of 
DNA has been enhanced by coupling an exonuclease to 
the  process  and  reading  the  cleaved  nucleotides  (as 
developed by Oxford Nanopore [66]).
Although nanopore sequencing technologies continue 
to advance, simply showing the ability to sequence DNA, 
something  not  yet  demonstrated  by  nanopores  with 
natural DNA, is not sufficient. There needs to be a path 
to lower costs, longer reads, or higher accuracy relative to 
other  technologies  that  will  provide  nanopores  with  a 
unique  advantage  relative  to  other  methods.  Even  if 
reagent costs can be significantly reduced, sample pre-
para  tion  and  informatic  costs  remain  and  these  may 
become the dominant costs of sequencing and will vary 
depending on the technology being used. The ever-rising 
hurdles created by extant technology will not be easy to 
overcome.  With  the  variety  of  second  generation  and 
single-molecule  technologies  already  commercialized 
and  others  on  the  horizon,  there  will  need  to  be 
substantial  advances  on  many  fronts  to  make  these 
technologies commercially viable.
Conclusions
The  development  of  single-molecule  sequencing  in 
which  individual  DNA  or  RNA  molecules,  derived 
directly from biological samples, are sequenced not only 
in a massively parallel manner but also without any type 
of amplification before or during the sequencing reaction 
promises  yet  another  inflection  point  in  terms  of 
technology. It offers the potential for lower costs, higher 
throughput,  improved  quantitative  accuracy,  increased 
read lengths, and the ability to directly sequence RNA 
and  detect  methylation  and  other  nucleotide 
modifications. Just as second generation sequencing did 
not  completely  displace  first  generation  sequencing, 
single-molecule  sequencing  will  not  immediately 
displace  earlier  tech  nolo  gies.  First  generation,  second 
generation, and single-molecule sequencing will each be 
used for the biological problems to which they are most 
suited, with that range of problems changing over time 
as each technology is improved.
Although no one mode of single-molecule sequencing 
can yet provide all the advantages potentially attainable, 
rapid  progress  is  being  made  to  achieve  these  goals. 
Technologies such as the Helicos system using fluores-
cent  detection  are  now  available  commercially,  and 
others such as Pacific Biosciences and Life Technologies 
Starlight will be available soon. New methods that rely 
on the natural chemical properties of native DNA are 
still in their infancy but raise the hope that sequencing 
might at some point become even simpler and cheaper 
by avoiding the need for labeling DNA and the use of 
enzymatic activities. Because experimenters have such 
widely vary  ing requirements for the problems that need 
to be addressed, each should consider whether the best 
and most complete answer can be generated with older, 
sequencing-by-committee approaches or whether a true 
understanding of their biological questions requires the 
exquisite quantitative accuracy and in-depth sequencing 
power  of  a  single-molecule  approach.  Single-molecule 
sequencing  will  continue  to  advance  and  offer 
researchers  a  variety  of  options,  especially  in  the 
diagnostic and clinical fields.
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